𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A multivariate analysis of the survival of patients with aggressive lymphoma : Variations in the predictive value of prognostic factors during the course of the disease

✍ Scribed by Nicolas Mounier; Pierre Morel; Corinne Haioun; Bertrand Coiffier; Herve Tilly; Christian Chatelain; Pierre Lederlin; Antoine Thyss; Raoul Herbrecht; Christian Gisselbrecht; Eric Lepage

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
147 KB
Volume
82
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

for the Groupe d'Etudes des a standard method, prognostic factors were identified in a training sample and confirmed in a validation sample. The independently significant covariates were Lymphomes de l'Adulte then included in a step-function regression model (3-step) that permitted determi-1 Unite Β΄d'Information Me Β΄dicale, CHU Henri nation of their value in predicting the short term and long term survival of the Mondor, AP HP, Creteil, France. entire population.

RESULTS.

During the entire follow-up period (median, 5.5 years), lactate dehydro-

πŸ“œ SIMILAR VOLUMES

Prognostic factors in retroperitoneal sa
Prognostic factors in retroperitoneal sarcoma : A multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group
✍ Eberhard Stoeckle; Jean-Michel Coindre; Sylvie Bonvalot; Guy Kantor; Philippe Te πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 2 views

## BACKGROUND. Surgery is the main prognostic factor in retroperitoneal sarcoma. However, despite progress, surgery alone is rarely curative, and analysis of the causes of failures and of other prognostic factors are warranted to ascertain treatment orientations.

The prognostic value of p53 and c-erb b-
The prognostic value of p53 and c-erb b-2 immunostaining is overrated for patients with lymph node negative breast carcinoma : A multivariate analysis of prognostic factors in 613 patients with a follow-up of 14–30 years
✍ Wenche Reed; Einar Hannisdal; Per Johannes Boehler; Stein Gundersen; Herman Host πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 105 KB πŸ‘ 2 views

## BACKGROUND. Approximately 30% of breast carcinoma patients with negative lymph nodes die of their disease. Biologic markers such p53 protein and c-erb B-2 have been related to tumor progression, but their prognostic value remains controversial. ## METHODS. Two large series of a total of 613 ly

CEOP treatment results and validity of t
CEOP treatment results and validity of the International Prognostic Index in Chinese patients with aggressive non-Hodgkin's lymphoma
✍ C. S. Chim; Y. L. Kwong; A. K. W. Lie; C. K. Lee; R. Liang πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 125 KB

From 1991 to 1997, we have treated 78 newly diagnosed patients with aggressive non-Hodgkin's lymphoma with a modified CHOP regimen in which epirubicin (60 mg/m 2 ) was used in place of doxorubicin (50 mg/m 2 ), i.e. CEOP (cyclophosphamide, epirubicin, vincristine and prednisolone). The median age wa